Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Vertex Pharmaceuticals (VRTX)
NASDAQ:VRTX
Holding VRTX?
Track your performance easily
See the Price Targets and Ratings of:
VRTX Analyst Ratings
Moderate Buy
16 Buy
9 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
VRTX Stock 12 Month Forecast
Average Price Target
$515.11
▲(9.34% Upside)
| Highest Price Target$600.00 | Average Price Target$515.11 | Lowest Price Target$361.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Truist Financial
Assigned
10/30/24
Oppenheimer
Reiterated
10/30/24
Canaccord Genuity
Reiterated
10/30/24
Wells Fargo
Reiterated
10/29/24
Scotiabank
Reiterated
10/28/24
Barclays
Reiterated
10/25/24
Evercore ISI
Assigned
10/24/24
Piper Sandler
Reiterated
10/23/24
Leerink Partners
Reiterated
10/21/24
H.C. Wainwright
Reiterated
10/21/24
Goldman Sachs
$595→$598
Buy
26.93%
Upside
Reiterated
10/21/24
Goldman Sachs reiterates Buy Rating on Vertex (VRTX)Goldman Sachs analyst Salveen Richter reiterated a Buy rating and $598.00 price target on Vertex (NASDAQ: VRTX).
Morgan Stanley
$473
Hold
0.40%
Upside
Reiterated
10/21/24
Cautious Hold on Vertex Pharmaceuticals Amidst Limited New Insights and Awaited Data
J.P. Morgan
―
Buy
―
Reiterated
10/21/24
Vertex Pharmaceuticals: Strategic Growth and Promising Drug Development Drive Buy Rating
TD Cowen
$525
Buy
11.44%
Upside
Reiterated
10/21/24
TD Cowen Sticks to Their Buy Rating for Vertex Pharmaceuticals (VRTX)
William Blair
―
Buy
―
Reiterated
10/21/24
Analysts Offer Insights on Healthcare Companies: Exelixis (NASDAQ: EXEL), Korro Bio (NASDAQ: KRRO) and Vertex Pharmaceuticals (NASDAQ: VRTX)
Best Analysts Covering Vertex Pharmaceuticals
Which Analyst Should I Follow If I Want to Buy VRTX and Sell After:
1 Month
xxx
Success Rate
9/13 ratings generated profit
Average Return
+2.88%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 69.23% of your transactions generating a profit, with an average return of +2.88% per trade.
3 Months
xxx
Success Rate
16/20 ratings generated profit
Average Return
+6.44%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 80.00% of your transactions generating a profit, with an average return of +6.44% per trade.
1 Year
Success Rate
12/13 ratings generated profit
Average Return
+25.17%
reiterated a buy rating 2 months ago
Copying Olivia Brayer's trades and holding each position for 1 Year would result in 92.31% of your transactions generating a profit, with an average return of +25.17% per trade.
2 Years
xxx
Success Rate
12/13 ratings generated profit
Average Return
+29.58%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 92.31% of your transactions generating a profit, with an average return of +29.58% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
VRTX Analyst Recommendation Trends
Rating
Jun 24
Jul 24
Aug 24
Sep 24
Oct 24
Strong Buy
0
0
0
0
0
Buy
41
28
27
19
31
Hold
13
11
12
9
21
Sell
5
3
2
2
2
Strong Sell
0
0
0
0
0
total
59
42
41
30
54
Each month's total comprises the sum of three months' worth of ratings.
VRTX Financial Forecast
VRTX Stock Forecast FAQ
What is VRTX’s average 12-month price target, according to analysts?
Based on analyst ratings, Vertex Pharmaceuticals’s 12-month average price target is $515.11.
What is VRTX’s upside potential, based on the analysts’ average price target?
Vertex Pharmaceuticals has 9.34% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is VRTX a Buy, Sell or Hold?
Vertex Pharmaceuticals has a consensus rating of Moderate Buy which is based on 16 buy ratings, 9 hold ratings and 1 sell ratings.
What is Vertex Pharmaceuticals’s price target?
The average price target for Vertex Pharmaceuticals is $515.11. This is based on 26 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $600.00 ,the lowest forecast is $361.00. The average price target represents 9.34% Increase from the current price of $471.12.
The highest analyst price target is $600.00 ,the lowest forecast is $361.00. The average price target represents 9.34% Increase from the current price of $471.12.
What do analysts say about Vertex Pharmaceuticals?
Vertex Pharmaceuticals’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 26 Wall Streets Analysts.
How can I buy shares of VRTX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.